Corporate Overview

Business Overview

Discovery

Delta4 Leverages AI to Maximize Efficiency and Success in Drug Discovery & Indication Expansion.

At Delta4, we are passionate about revolutionizing drug discovery and drug indication expansion for the most complex diseases. As a leading TechBio company, we are resolute in our mission to develop innovative treatments for patients in need.

Our passion is driven by our commitment to using the most advanced proprietary technology and data, combined with the brightest minds in the industry, to develop groundbreaking treatments and life-saving cures. We use a multi-pronged approach to drug discovery and drug repositioning, combining the best of both worlds in terms of modern research and development.

We are proud to be at the forefront of artificial intelligence (AI) when it comes to drug discovery and drug repositioning. We leverage the power of AI to identify and analyze the most promising treatments and cures, giving us the ability to develop treatments quickly and efficiently while saving time and money. Our AI-powered technology enables us to uncover the hidden potential in drug candidates with known safety profiles, as well as identify new pathways and targets for drug development.

At Delta4, we believe that the future of drug discovery and drug repositioning lies in artificial intelligence (AI). Our mission is to use AI-powered technologies to propel us forward in the fight against complex diseases and to deliver innovative treatments that can improve the lives of those suffering from them.

Our Pipeline

Our platform leverages sophisticated algorithms, data-driven optimization, and a rigorous validation process to ensure the accuracy of our models. This approach allows us to develop drugs quickly and more efficiently, enabling us to bring our discoveries to market faster.

Development

Learn More About Our Business

We’re always working on creating and developing the treatments of tomorrow. Our work yields lucrative results ranging from valuable patents filed with in-silico data that can secure royalties, to coveted assets backed by clinical data that can be sold to pharmaceutical companies.

Learn more about investment opportunities with Delta4.

Our Partners & Clients

It’s an honor and a privilege to be working with the best of the best!

Proud Member of Scientist.com

Streamlining Transparency and Cooperation

Scientist.com provides a unique platform where researchers and suppliers can both find each other and work together more easily. They provide a collaboration framework to streamline the typically long and tedious process of defining the terms and conditions of an agreement.
Members can work together smoothly and effortlessly by agreeing to the rules of the platform. The result is that together we can achieve the results we need faster.

“Delta4’s AI-Powered Hyper-C Platform Uncovers New Drug Indications, Expanding Treatment Potential for Iguratimod” – As Featured on Scientist.com

Are you a member of Scientist.com? View Our Profile

Get Involved

Learn how you can contribute to the exciting work happening at Delta4

Careers

Forging the innovative treatments of the future requires brilliant minds and we’re always on the lookout for talent.

Investors

Medical Community

Learn how you can partner with us and combine our technology with your knowledge to develop treatments faster.